Alert detail
LCD L39650: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules — CGS Administrators
Policy ID: LCD-L39650Specialty: OutpatientAdded: 6/5/2026Effective: 2026-05-28lcd
What changed
New LCD for thyroid nodule risk stratification testing.
Who’s affected: Outpatient billing teams · Effective: 2026-05-28
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.
Not ready to subscribe?
Get the free weekly reimbursement brief for Outpatient— the week’s changes and deadlines, delivered to your inbox. No account required.